5-163441320-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_004060.4(CCNG1):āc.507G>Cā(p.Leu169Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000845 in 1,613,404 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_004060.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCNG1 | NM_004060.4 | c.507G>C | p.Leu169Phe | missense_variant | 3/7 | ENST00000340828.7 | NP_004051.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCNG1 | ENST00000340828.7 | c.507G>C | p.Leu169Phe | missense_variant | 3/7 | 1 | NM_004060.4 | ENSP00000344635.2 | ||
CCNG1 | ENST00000510664.5 | c.123G>C | p.Leu41Phe | missense_variant | 3/7 | 5 | ENSP00000422379.1 |
Frequencies
GnomAD3 genomes AF: 0.000480 AC: 73AN: 152168Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000431 AC: 108AN: 250670Hom.: 0 AF XY: 0.000391 AC XY: 53AN XY: 135572
GnomAD4 exome AF: 0.000883 AC: 1290AN: 1461236Hom.: 1 Cov.: 31 AF XY: 0.000861 AC XY: 626AN XY: 726902
GnomAD4 genome AF: 0.000480 AC: 73AN: 152168Hom.: 0 Cov.: 33 AF XY: 0.000430 AC XY: 32AN XY: 74348
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 15, 2021 | The c.507G>C (p.L169F) alteration is located in exon 3 (coding exon 2) of the CCNG1 gene. This alteration results from a G to C substitution at nucleotide position 507, causing the leucine (L) at amino acid position 169 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at